Senior insider sale
President and CEO at ARTIVA BIOTHERAPEUTICS, INC. — senior position signals high conviction
$216.6K
44.62K shares
What this filing means
ASLAN FRED plans to sell 44.62K shares of ARTIVA BIOTHERAPEUTICS, INC. valued at approximately $216.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/15/2025ACC: 0001950047-25-010318
DirectorOfficer· President and CEO
Since Feb 2026
44.62K
Shares to sell
$216.6K
Approx. market value
12.75K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
11/15/2025
12.75KTotal acquired12.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2025 | Restricted Stock Units N/A | 12.75K | — |
| Total | 12.75K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
6.38K
Market value
$21.5K
11/17/2025
—Completed
Units to sell
25.50K
Market value
$153.0K
10/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.75K
Market value
$42.1K
12/15/2025
Total
Units
44.62K
Value
$216.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/17/2025 | 6.38K | $21.5K | — | Completed |
10/17/2025 | 25.50K | $153.0K | — | Completed |
| Planned — Approximate Date | ||||
12/15/2025 | 12.75K | $42.1K | NASDAQ | Planned |
| Total | 44.62K | $216.6K | ||